New insights into the molecular basis of progressive myoclonus epilepsy: A multiprotein complex with cystatin B

78Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cystatin B is an anti-proteolytic polypeptide implicated in progressive myoclonus epilepsy (EPM1), a degenerative disease of the central nervous system. The knock-out mouse model of the disease shows apoptosis of the cerebellar granule cells. We have identified five recombinant proteins interacting with cystatin B and none of them is a protease. We show that three of these proteins (RACK-1, β-spectrin and NF-L) co-immunoprecipitate with cystatin B in rat cerebellum. Confocal immunofluorescence analysis shows that the same proteins are present in the granule cells of developing cerebellum, as well as in Purkinje cells of adult rat cerebellum. We propose that a cystatin B multiprotein complex has a specific cerebellar function and that the loss of this function might contribute to the disease in EPM1 patients.

Cite

CITATION STYLE

APA

Di Giaimo, R., Riccio, M., Santi, S., Galeotti, C., Ambrosetti, D. C., & Melli, M. (2002). New insights into the molecular basis of progressive myoclonus epilepsy: A multiprotein complex with cystatin B. Human Molecular Genetics, 11(23), 2941–2950. https://doi.org/10.1093/hmg/11.23.2941

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free